Recent studies revealed an epidemiological association between circulating Gal-3 levels and the risk of AF incidence in a community-derived population [11, 12], which is biologically plausible since both myocardial fibrosis and HF are primary risk factors for AF [13, 14]. This evidence concerns the gene LGALS3 and Myocardial fibrosis.